DeepScribe vs Vero: AI Medical Scribe Comparison

DeepScribe is one of the most credentialed ambient AI scribes available. It holds a 98.8/100 KLAS score — the highest reported in the ambient AI category — and powers documentation across the U.S. Oncology Network, Texas Oncology, Florida Cancer Specialists, and New York Cancer & Blood Specialists. Its proprietary HEAL large language model, trained on over 3 million labeled clinical conversations, has been validated in peer-reviewed oncology research. For large specialty networks and enterprise health systems, DeepScribe is a serious product.

Vero is a different kind of tool. It starts at $69/month, you can sign up and start your first encounter in minutes, and it is built for clinicians who want a broader documentation workflow without enterprise friction.

The two tools serve different clinical contexts. This comparison covers pricing, features, real physician feedback, and an honest verdict on which is the stronger fit for different types of practices.

For a deeper look at DeepScribe on its own terms, see our DeepScribe Review 2026.

Pricing: DeepScribe vs Vero

DeepScribe does not publish pricing. All plans require a sales conversation, and evaluation typically involves a demo call, scoping discussion, and implementation period before you see a number. Based on third-party market data, verified Capterra reviews, and physician forum disclosures, the estimated range is $350–$500+ per provider per month on annual contracts.

Plan	DeepScribe	Vero
Free Tier	None	10 encounters/month, forever
Free Trial	14-day trial reportedly available via sales	7 days full access, no credit card
Individual / Monthly	Not available (enterprise only)	$89/month
Individual / Annual	~$350–$500+/month (estimated)	$69/month ($828/year)
Enterprise	Custom quote	Custom — contact sales
Setup Fee	$500–$1,000 reported	$0
Student / Trainee	Not available	Discounted rate available
Self-Serve Signup	No — sales call required	Yes — instant, no credit card
Contract Terms	Annual required, auto-renewing	Monthly or annual, cancel anytime

The pricing gap is substantial — Vero's annual plan costs roughly 5–7x less than DeepScribe's estimated base rate. But the structural difference matters just as much as the dollar figure. DeepScribe requires a multi-step sales and implementation process before you can access the product. Vero is available the moment you create an account.

Feature Comparison

Feature	DeepScribe	Vero
Monthly Price	~$350–$500+	$69 annual / $89 monthly
Free Tier		10/month
Free Trial	Via sales	7 days
Signup	Sales-led	Self-serve
Ambient Scribe
Note Speed	Hours	Seconds to minutes
Human QA
Input Methods	Audio only	Audio + text + uploads
File Uploads
AI Chat
Style Learning
Clinical Insights
Evidence Engine
PDF Auto-Fill
Patient Profiles
Snippets
Custom Templates
ICD-10 Coding		+ ICD-10-CA
Advanced Coding
Note Controls	Customization Studio	Detail + format controls
Telehealth	Limited
Mobile App	iOS only	iOS + Android
Languages	English only	60
Specialties	Oncology-focused	150+
HIPAA
PIPEDA	Not confirmed
Audio Retention	Not disclosed	None
Trainee Pricing
Team Features

Where DeepScribe Wins

KLAS score and institutional validation

DeepScribe's 98.8/100 KLAS score is the highest reported in the ambient AI category. That number carries weight in enterprise procurement decisions — it signals peer-validated clinical performance at scale, not just a vendor claim. A peer-reviewed study published in the Journal of Clinical Pathways (August 2025) tracked DeepScribe across a major oncology network and found a 16% increase in diagnoses captured per visit, 22% increase in comorbidity documentation frequency, and 45% increase in social determinants of health documentation. These are real-world, published results.

For a health system CIO or clinical informatics leader vetting ambient AI vendors, this institutional paper trail is genuinely valuable.

Human QA layer

Every note DeepScribe generates is reviewed by a trained human before it reaches the clinician. The obvious tradeoff is delivery time — notes arrive hours after the encounter, not seconds. The institutional benefit is an auditable, defensible documentation workflow where every note has been checked by a human before it enters the chart. For high-stakes oncology documentation or complex specialty settings where a missed detail has downstream consequences, this is a meaningful differentiator.

Advanced coding suite

DeepScribe's coding capabilities go beyond ICD-10. The platform generates HCC (Hierarchical Condition Category) codes for comorbidity capture in value-based care programs, E/M level suggestions based on documented visit complexity, and CPT code flagging with audit-ready documentation. For practices with active value-based care contracts — where HCC coding completeness directly affects risk adjustment and reimbursement — this suite has real financial consequences.

Deep oncology specialization

DeepScribe's HEAL LLM was trained on over 3 million labeled clinical conversations, and the company reports capturing approximately 3.1 million cancer care visits annually across the U.S. Oncology Network, Texas Oncology, Florida Cancer Specialists, and other major networks. This depth of oncology-specific training data translates to documentation quality that is hard to replicate with a general-purpose model. For oncology practices specifically, DeepScribe's vertical focus is a genuine differentiator.

Where Vero Wins

Vero wins on the parts of the workflow that matter most to independent and small-group practices.

• Faster note closure — DeepScribe's human QA layer can be valuable in enterprise settings, but it also means notes arrive later. Vero is built for clinicians who want charts done the same visit.
• Lower-friction adoption — Self-serve signup, lower pricing, and no enterprise rollout make Vero much easier to evaluate if you are not buying for a large oncology network.
• Broader documentation workflow — Uploads, AI chat, adaptive learning, PDF auto-fill, and evidence support make Vero more useful when the visit involves more than ambient audio alone.
• Better outside DeepScribe's core niche — DeepScribe is strongest in oncology and enterprise specialty settings. Vero is broader across specialties, languages, mobile use, and Canadian compliance.
• Cleaner privacy defaults — Zero audio retention and explicit PIPEDA support make the product easier to recommend for Canadian clinics and privacy-sensitive specialties.

What Users Say About DeepScribe

We reviewed feedback from KLAS, Capterra (4.3/5 stars), Reddit, and physician forums.

What physicians like:

• "DeepScribe has given me back my weekends and has given me back my life." — Carol C., Capterra
• "Charting down from approximately 10 to 15 minutes per chart down to 3 to 5." — Carol C., Capterra
• "We have completely eliminated after-hours documentation because now, their notes are produced in real time." — VP, KLAS Spotlight Report, September 2024
• "DeepScribe Ambient AI has fabulous quality; we just click one button, and the system works." — VP, KLAS, October 2024
• "Their customer service is absolutely second to none." — Director, KLAS, August 2024

What physicians find limiting:

• Contract lock-in — "Automatically renewing contract…you are stuck for another 12 months." — Leslie D., Capterra. Annual auto-renewal is a recurring concern for practices that want flexibility to switch tools.
• Note delivery delay — "Sometimes the AI does not transcribe complete notes and I have to reprocess them." — Paul B., Capterra. Even with human QA, some notes require additional editing after delayed delivery.
• iOS-only recording — "Every time your phone rings it stops the visit." — Leslie D., Capterra. The iOS app has reported reliability issues during active encounters.
• Enterprise pricing — Reddit threads in r/medicine and r/physicianassistant consistently describe DeepScribe as less practical for independent or small-practice clinicians. One physician called it "intriguing and effective but quite expensive and requires a 1-year commitment."
• Sales-gated access — "Save some money. There are better products for 75% less." — Leslie D., Capterra

For the full picture, see our DeepScribe Review 2026.

Frequently Asked Questions

How much does DeepScribe cost compared to Vero?

DeepScribe does not publish pricing. Based on third-party reports and verified user reviews, the estimated range is $350–$500 per provider per month on annual contracts, with additional setup fees of $500–$1,000 reported for smaller practices. Vero costs $69/month on an annual plan ($828/year) with a 7-day free trial, a permanent free tier of 10 encounters/month, and no setup fees. You can start using Vero without a sales call or credit card.

Is DeepScribe available for solo or small-group practices?

DeepScribe is designed for enterprise health systems and large specialty networks. While solo practitioners can technically contact sales, the pricing model (~$350–$500+/month), annual contract requirements, auto-renewal policies, and implementation costs make it less practical for independent clinicians. Vero is available to any clinician — sign up at secure.veroscribe.com/signin/signup and start your first encounter in minutes.

Does DeepScribe work with Android?

No. DeepScribe's recording app is iOS only. Android is not supported, which is a frequently cited limitation in physician forums and user reviews. Vero supports both iOS and Android.

How long does it take to get notes from DeepScribe?

DeepScribe uses a human-in-the-loop quality assurance layer — every AI-generated note is reviewed by a human before delivery to the clinician. This improves auditability but means notes typically arrive hours after the encounter. Vero generates and delivers notes in seconds to minutes. If same-visit chart closure is part of your workflow, this difference is worth weighing carefully.

Is DeepScribe HIPAA compliant?

Yes. DeepScribe is HIPAA compliant and SOC 2 Type II certified. Their published compliance covers U.S. healthcare privacy standards. Canadian practices requiring PIPEDA compliance should verify directly with DeepScribe, as PIPEDA certification is not confirmed on their website. Vero is certified under both HIPAA and PIPEDA, with zero audio retention by default.

Can I use Vero for the same specialties as DeepScribe?

Vero supports 150+ specialties including all the specialty areas DeepScribe covers — cardiology, gastroenterology, neurology, orthopedics, urology — as well as dental, nursing, allied health, mental health, veterinary, and alternative medicine. DeepScribe's deepest vertical is oncology; Vero does not have DeepScribe's HCC coding depth for value-based oncology programs, but covers a broader range of clinical contexts overall.

Final Verdict: DeepScribe vs Vero

These two tools serve different clinical contexts, and the comparison is cleaner when framed that way.

DeepScribe is the stronger fit for large group practices, specialty networks, and enterprise health systems — particularly those with active oncology programs, value-based care contracts, and the procurement infrastructure to support a 12-month enterprise deployment. The 98.8/100 KLAS score, published peer-reviewed research, human QA layer, and HCC coding suite are real capabilities that carry weight in institutional settings. DeepScribe is a legitimate enterprise tool, and for practices where it fits, it fits well.

For most other clinicians — independent practitioners, small group practices, telehealth providers, allied health professionals, residents, fellows, multilingual clinics, and Canadian providers — the value equation shifts. If your workflow depends on same-visit chart closure, self-serve access, Android support, multilingual transcription, or a price point below $100/month, Vero is the more natural fit.

If your practice context matches what DeepScribe was built for, it remains a strong choice. For everyone else, Vero is easier to trial, easier to adopt, and better aligned with general clinical documentation rather than oncology-heavy enterprise workflows.